Industry Focus
Healthcare: How’s It Going to Be for AbbVie, Regeneron, Clovis, and More
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:04
- Mas informaciones
Informações:
Sinopsis
AbbVie is developing new drugs to sidestep expiring patents on its best-seller, and a new FDA approval could be on deck at Clovis Oncology. Also, how Novartis plans to shake-up a multibillion dollar indication.
